Delivra Health | DreamWater | LivRelief
Delivra Health Brands logo
toggle menu

0.04 - 0.01

Harvest One Announces Closing of $5.75 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

March 17, 2021 – Vancouver, British Columbia – Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQB: HRVOF), a uniquely positioned cannabis-infused CPG leader, is pleased to announce the closing of its bought-deal short-form prospectus offering pursuant to which the Company issued 37,096,700 units of the Company (the “Units”) at a price of $0.155 per Unit for gross proceeds to the company of approximately $5.75 million (the “Offering”), including the full exercise of an over-allotment option.

Mackie Research Capital Corporation, as sole bookrunner, and ATB Capital Markets Inc., acted as co-lead underwriters of the Offering.

Each Unit consists of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of $0.195 at any time until March 17, 2024.

The net proceeds of the Offering will be used to expand the Company’s existing product lines and distribution channels, and for working capital and general corporate purposes.

The TSX Venture Exchange (the “TSXV”) has conditionally approved the listing of the Common Shares and the Warrants. It is expected that the Warrants will commence trading on the TSXV on or about March 19, 2021 under the trading symbol “HVT.WT”.

The securities referred to in this press release have not been, nor will they be, registered under the U.S. Securities Act or any U.S. state securities laws, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This press release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities in the United States, nor in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

About Harvest One

Harvest One is a global cannabis-infused CPG company that develops and distributes premium health, wellness and selfcare products with a market focus on sleep, and pain. Harvest One is a uniquely positioned company in the cannabis space with a focus on cannabis infused and non-infused consumer packaged goods.  Harvest One owns and operates two subsidiaries: Dream Water Global and LivRelief. For more information, please visit

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance about Harvest One, its business and its operations, and the Offering, which include, among other things, the intended use of proceeds of the Offering, Harvest One’s corporate strategy moving forward and future opportunities available for the Company. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Colin Clancy
Investor Relations

Email Signup